In hepatocellular carcinoma, IRGM enhances the interaction between YBX1 and S6K1 kinase, increasing YBX1 phosphorylation and nuclear localization, and enhancing PD-L1 transcription (119). This evidence concerns the gene YBX1 and hepatocellular carcinoma.